Clinical Trial Update: A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and immunogenicity of GC3111 in healthy adults for tetanus, diphtheria, and pertussis. Status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Tetanus
• Whooping Cough

Drugs mentioned

• GC3111

Snippet

Sponsor: Green Cross Corporation | Conditions: Tetanus, Diphtheria | Phase 2 | Status: UNKNOWN